3064
J. Am. Chem. Soc. 2001, 123, 3064-3068
How Curcumin Works Preferentially with Water Soluble Antioxidants
Slobodan V. Jovanovic,*,† Charles W. Boone,‡ Steen Steenken,§ Manuela Trinoga,§ and
Robert B. Kaskey
Contribution from Helix International, 381 Viewmount DriVe, Nepean, ON, Canada K2E 7R9, Department
of Pathology, Georgetown UniVersity Medical School, Washington, DC, Max-Planck-Institut fu¨r
Strahlenchemie, 34-36 Stiftstrasse, Mu¨lheim, Germany, and Gene Print, Inc., Bala Cynwyd, PennsylVania
ReceiVed October 30, 2000. ReVised Manuscript ReceiVed February 2, 2001
Abstract: In this study we investigated physicochemical characteristics of the curcumin radical by pulse
radiolysis and laser flash photolysis. Two methylated curcumin derivatives, methylcurcumin and trimethyl-
curcumin, were synthesized to explore the role of phenol hydroxy and â-diketone moieties in the free radical
chemistry of curcumin. Our results show that the initially generated â-oxo-alkyl transforms rapidly, probably
via an intramolecular H-atom shift, into the phenoxyl-type curcumin radical. This phenoxyl does not react
with oxygen, k < 105 M-1 s-1, and can be repaired by any water-soluble antioxidant with appropriate redox
potential, E6 < 0.83 V, for example, with vitamin C, k ) (6 ( 1) × 106 M-1 s-1. A molecular mechanism
of cancer chemoprevention by curcumin is proposed, with special emphasis on the synergism with water-
soluble antioxidants.
Introduction
of protein kinases,8 and especially its neutralization of car-
cinogenic free radicals.9,15-25 It is possible that any one, more
than one, or all of these biological, biochemical, and chemical
mechanisms are responsible for the anticarcinogenic potential
of curcumin. While biological and biochemical mechanisms tend
to be tissue and organ specific, chemical anti-carcinogenesis,
e.g. free radical neutralization, works at all levels of a biological
system.
Numerous studies have demonstrated the remarkable cancer
preventive properties of curcumin.1-10 This natural antioxidant
inhibits cancerous growth in various cancer models alone and
in combinations with other “plant phenolics”. The chemopre-
ventive effects of curcumin have been attributed to various
properties, including its anti-angiogenesis action,11,12 which
limits the blood supply to rapidly growing malignant cells, its
stimulation of Phase I and Phase II detox systems, e.g. inhibition
of COX-1 and COX-2 enzymes, and stimulation of glutathione
S-transferase,13,14 its interference with cell growth by inhibition
Of particular interest is the ability of curcumin to intercept
and neutralize potent chemical carcinogens, such as ROS
(superoxide, peroxyl, hydroxy radicals) and NOS (nitric oxide,
peroxynitrite).9,15-25 The inactivation of carcinogenic free
radicals, which induce and propagate chemical and biochemical
processes involved in the inflammatory response, could be the
major chemical anti-carcinogenic mechanism of curcumin and
curcuminoids. It is usually assumed that the phenol moiety is
responsible for antioxidant properties of any plant phenolic
compound. Consequently, the free radical chemistry of curcumin
(an o-methoxyphenol derivative) has focused on its phenol
rings.15,17-19 Other studies have pointed to the possible involve-
ment of the â-diketone moiety in the antioxidant action of
curcumin and its derivatives.9,25,26 A recent report by some of
us24 describes the H-atom donation from the â-diketone moiety
† Helix International.
‡ Georgetown University Medical School.
§ Max-Planck-Institut fu¨r Strahlenchemie.
Gene Print, Inc.
(1) Cheng, A. L.; Lin, J. K.; Hsu, M. M.; Shen, T. S.; Ko, J. Y.; Lin, J.
T.; Lin, B. J.; Wu, M. S.; Yu, H. S.; Jee, S. H.; Chen, G. S.; Chen, T. M.;
Chen, C. A.; lai, M. K.; Pu, Y. S.; Pan, M. H.; Wang, Y. J.; Tsai, C. C.;
Hsieh, C. Y. American Society of Clinical Oncology, 1998 Annual Meeting;
Abstract 2140.
(2) Singh, S. V.; Hu, X.; Srivastava, S. K.; Singh, M.; Xia, H.; Orchard,
J. L.; Zaren, H. A. Carcinogenesis 1998, 19, 1357.
(3) Khafif, A.; Schantz, S. P.; Chou, T. C.; Edelstein, D.; Sacks, P. G.
Carcinogenesis 1998, 19, 419.
(4) Reddy, B. S.; Kawamori, T.; Rao, C. V.; Lubet, R. A.; Steele, V. E.;
Kelloff, G. J. Proc. Am. Assoc. Cancer Res. 1979, 39, 126.
(5) Kawamori, T.; Lubert, R.; Steele, V. E.; Keloff, G. J.; Kaskey, R.
B.; Rao, C. V.; Reddy, B. S. Cancer Res. 1999, 59, 597.
(6) Samaha, H. S.; Keloff, G. J.; Steele, V.; Rao, C. V.; Reddy, B. S.
Cancer Res. 1997, 57, 1301.
(7) Wargovich, M. J.; Chen, C.-D.; Jimenez, A.; Steele, V. E.; Velasco,
M.; Stephens, L. C.; Price, R.; Gray, K.; Keloff, G. J. Cancer Epid. Biom.
PreV. 1996, 5, 355.
6508001.html.
(9) Masuda, T.; Hidaka, K.; Shimohara, A.; Maekawa, T.; Takeda, Y.;
Yamaguchi, H. J. Agric. Food Chem. 1999, 47, 71.
(10) Verma, S. P.; Salamone, E.; Goldin, B. Biochem. Biophys. Res.
Commun. 1997, 233, 692.
(11) Thaloor, D.; Singh, A. K.; Sidhu, G. S.; Prasad, P. V.; Kleinman,
H. K.; Maheswari, R. K. Cell Growth Differ. 1998, 9, 305.
(12) Arbiser, J. L.; Klauber, N.; Rohan, R.; Vanleeuwen, R.; Huang, M.
T.; Fisher, C.; Flynn, E.; Byers, H. R. Mol. Med. 1998, 4, 376.
(13) Venkatesan, N. Br. J. Pharmacol. 1998, 124, 425.
(14) Rajakrishnan, V.; Viswanathan, P.; Rajasekaran, K. N.; Gunasheka-
ran, G.; Menon, V. P. Med. Sci. Res. 1998, 26, 715.
(15) Anto, R. J.; Kuttan, G.; Babu, K. V. D.; Rajasekharan, K. N. Int. J.
Pharmaceut. 1996, 131, 1.
(16) Chignell, C. F.; Bilski, P.; Reszka, K. J.; Motlen, A. G.; Sik, R. H.;
Dahl, T. A. Photochem. Photobiol. 1994, 59, 295.
(17) Gorman, A. A.; Hamblett, I.; Srinavasan, V. S.; Wood, P. D.
Photochem. Photobiol. 1994, 59, 389.
(18) Priyadarsini, K. I. Free Radicals Biol. Med. 1997, 23, 1997.
(19) Priyadarsini, K. I.; Devasagayam, T. P. A.; Rao, M. N. A.; Guha,
S. N. Radiat. Phys. Chem. 1999, 54, 551.
(20) Sreejayan, N.; Rao, M. N. A. Arzneim.-Forsch. 1996, 46, 169.
(21) Sreejayan, N.; Rao, M. N. A. J. Pharm. Pharmacol. 1997, 49, 105.
(22) Unnikrishnan, M. K.; Rao, M. N. A. Mol. Cell. Biochem. 1995,
146, 35.
(23) Souza, C. R. A.; Osme, S. F.; Gloria, M. B. A. J. Food Proc.
PreserV. 1997, 21, 353.
(24) Jovanovic, S. V.; Steenken, S.; Boone, C. W.; Simic, M. G. J. Am.
Chem. Soc. 1999, 121, 9677.
(25) Sugiyama, Y.; Kawakishi, S.; Osawa, T. Biochem. Pharmacol. 1996,
52, 519.
10.1021/ja003823x CCC: $20.00 © 2001 American Chemical Society
Published on Web 03/09/2001